This list is an analysis based on recent market events. It's not an investment recommendation.
About
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, sterile carbapenem, urological, neuromodulator, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company offers drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.
The current price of KOPRAN.NSE is ₹155.23 INR — it has decreased by -3.7% in the past 24 hours. Watch Kopran stock price performance more closely on the chart.
What is Kopran stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kopran stocks are traded under the ticker KOPRAN.NSE.
Is Kopran stock price growing?▼
KOPRAN.NSE stock has fallen by -2.55% compared to the previous week, the month change is a +27.61% rise, over the last year Kopran has showed a -18.3% decrease.
What is Kopran revenue for the last year?▼
Kopran revenue for the last year amounts to 12.48B INR.
What is Kopran net income for the last year?▼
KOPRAN.NSE net income for the last year is 771.04M INR.
Does Kopran pay dividends?▼
Yes, KOPRAN.NSE dividends are paid annual. The last dividend per share was 3 INR. As of today, Dividend Yield (FWD)% is 1.93%.
How many employees does Kopran have?▼
As of April 25, 2026, the company has 1,024 employees.